AI and digital tools can help founders get started faster. The next step is making sure the results can actually support R&D decisions, fundraising, CMO discussions, and scale-up strategy. Recently, I have been getting a growing number of biotech, foodtech, and sustainable materials startups coming to me with a first-pass techno-economic analysis already in hand. Sometimes it was built with an AI tool. Sometimes it came from a digital twin platform. Sometimes it was developed

What do investors actually ask about biotech scale-up economics? This article explores the manufacturing questions that shape investor confidence, from cost of production and CAPEX to utilization, manufacturing route, and commercial scale.

What actually drives fermentation manufacturing cost? This article shows why biotech and foodtech startups can make real process improvements and still get surprised by the economics when hidden cost drivers like utilization, CAPEX, utilities, facility burden, and downstream complexity are not examined early through techno-economic analysis.

How big should a fermentation plant be? This article explains why the optimal production scale is rarely the biggest one a model can justify, and why utilization, CAPEX, demand ramp, and execution risk matter just as much as cost per kg.

Early-stage biotech and foodtech startups rarely fail because their science doesn’t work. They struggle when unit economics, capital intensity, and scale assumptions are framed too late. In this article, I explain why I developed the ScaleUpReady™ framework — and how order-of-magnitude techno-economic analysis can transform industrial decision-making before millions are committed.

Running a Bioprocess Pilot Trial: A Comprehensive Guide to Capturing Critical Data ======================================================================================== Running a bioprocess pilot trial is one of the most expensive and time-intensive steps in scaling a fermentation or bioindustrial process. Pilot runs can take weeks or even months to plan. Yet, the data generated during just a few days is used to inform critical scale-up, process design, and business decisi

Even after 20+ years in process development and industrial scale-up, techno-economic analyses continue to reveal unexpected constraints. This article explores the real-world surprises TEAs uncover — and why seeing them early can change how startups design, scale, and invest.

A good TEA doesn’t just calculate cost — assumptions. It shows founders: What must be true for the economics to work Where the biggest levers are Which risks matter and which don’t What plant size is required to hit target COGS What commercial-scale unit operations actually look like Most importantly: A TEA brings science, engineering, and business into the same conversation — something that rarely happens early enough in some startups. If you’re building a biotech, food-tech

Every founder scaling a biotech or foodtech process knows the feeling, lying awake at 2 a.m., running scenarios in their head: Where should we build? When will be the right time? And how big before it’s too big? Techno-Economic Analysis (TEA) gives you a framework to answer all three, with data, not gut feeling or personal preferences. It translates technical progress into business logic, helping founders make decisions that investors trust. 1️⃣ WHERE — Site & Region Selectio

Scaling up a bioprocess from the laboratory to a pilot plant or from pilot to demo is one of the most exciting and risky stages for any startup. The leap from proof-of-concept to pilot or industrial production brings not only technical challenges but also financial uncertainty. That’s where Techno-Economic Analysis (TEA) comes in. At Sustech Innovation, we help biotech, foodtech, and sustainable-materials companies translate their technical data into clear economic insights,

When scaling up a biotech or food-tech process, the big question isn’t just “is it feasible?”. It’s “will this process make sense economically at commercial scale?” Traditional project feasibility studies cover technical, legal, and operational aspects. But in capital-intensive industries like precision fermentation, cultivated meat, and bio-based materials, feasibility alone is not enough. What really matters is whether your process will work technically and economically onc

(Hint: It’s not just about cost per kg, it’s about stepping back from R&D and seeing the full picture) I’ve heard this many times: “We just need a basic TEA and a cost per kg.” That’s definitely not what a good TEA does. Let’s break it down 👇 Common Misconceptions About TEA ❌ What some founders think a TEA is: A spreadsheet with OPEX and CAPEX Something you do after scale-up Just a tool for fundraising or facility design But that’s like saying a GPS is only useful after you’

I hear this a lot from founders: 👉 “Our plan is to use CMOs.” 👉 “We’ll license the tech anyway, so why bother with a facility TEA?” Understanding the Importance of a Facility TEA Here’s the thing: A facility TEA doesn’t mean you’re committing to build a factory. It’s simply the best way to estimate the true cost per kg of your product. This is the baseline economics you need to: ✔ Negotiate with CMOs ✔ Pitch to investors ✔ License your tech with confidence Why It Matters 1️

I hear this often. And every time, my brain freezes for a second. 🤯 Why? Because 𝐭𝐡𝐚𝐭’𝐬 𝐚𝐜𝐭𝐮𝐚𝐥𝐥𝐲 𝐭𝐡𝐞 𝐩𝐞𝐫𝐟𝐞𝐜𝐭 𝐦𝐨𝐦𝐞𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐫𝐭 𝐲𝐨𝐮𝐫 hashtag#TechnoEconomicAnalysis. Here’s why: 🔄 𝐕𝐚𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐓𝐄𝐀 𝐚𝐫𝐞 𝐧𝐨𝐭 𝐬𝐞𝐪𝐮𝐞𝐧𝐭𝐢𝐚𝐥, 𝐭𝐡𝐞𝐲 𝐚𝐫𝐞 𝐩𝐚𝐫𝐚𝐥𝐥𝐞𝐥 𝐭𝐫𝐚𝐜𝐤𝐬 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐛𝐲 𝐟𝐞𝐞𝐝𝐛𝐚𝐜𝐤 𝐥𝐨𝐨𝐩𝐬. Run them together and your process development will stay guided by market and cost realit

Everyone talks about the “Valleys of Death” in biotech — but here’s one few mention: 🚨 Building your business case around the wrong production scale. 10,000 t/year looks impressive. “Economies of scale.” Investor confidence. Bigger = better… right? ❌ Not if your 𝐮𝐧𝐢𝐭 𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐜𝐬, 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐢𝐦𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐟𝐮𝐧𝐝𝐢𝐧𝐠 𝐫𝐮𝐧𝐰𝐚𝐲 can’t support it. Here’s what usually goes wrong: 𝐂𝐀𝐏𝐄𝐗 𝐞𝐱𝐩𝐥𝐨𝐝𝐞𝐬 – custom fermenters, oversized utilities (steam

INTRODUCTION Raising funds for a biotech, foodtech, or synbio startup is no longer just about storytelling; it's about evidence. Investors are asking sharper questions earlier in the game. They want to know: ▪️ What does your unit cost look like at scale? ▪️ Is your process actually viable beyond the lab? ▪️ How much capital will you need to spend before your process becomes profitable? This is where Techno-Economic Analysis (TEA) becomes a strategic tool. At Sustech Innov

You’re not alone, and here’s why it doesn’t have to be that way. 👋 If you're an early-stage founder trying to understand your production economics, you've probably hit this wall: 𝐌𝐨𝐬𝐭 𝐓𝐄𝐀 𝐭𝐨𝐨𝐥𝐬 𝐞𝐱𝐩𝐞𝐜𝐭 𝐲𝐨𝐮 𝐭𝐨 𝐚𝐥𝐫𝐞𝐚𝐝𝐲 𝐤𝐧𝐨𝐰 𝐲𝐨𝐮𝐫: ▪️ Microbial production rates ▪️ Doubling time ▪️ Densities & viscosities ▪️ Aeration flow rates ▪️ pH buffers ▪️ Membrane specs ▪️ Separation efficiencies 𝐀𝐥𝐥 𝐰𝐡𝐢𝐥𝐞 𝐲𝐨𝐮'𝐫𝐞 𝐬𝐭𝐢𝐥𝐥 𝐫𝐮𝐧𝐧𝐢𝐧𝐠 𝐬

In the journey from laboratory to commercial success, every decision counts. Yet many startups delay doing their TEA, assuming it’s only for the pilot plant onwards. Here’s why obtaining TEA insights at every stage can be a game-changer: 1️⃣ 𝐂𝐨𝐧𝐜𝐞𝐩𝐭 & 𝐅𝐞𝐚𝐬𝐢𝐛𝐢𝐥𝐢𝐭𝐲 – 𝐑𝐨𝐮𝐠𝐡 🚀 𝐓𝐨𝐨 𝐄𝐚𝐫𝐥𝐲 𝐭𝐨 𝐝𝐨 𝐲𝐨𝐮𝐫 𝐓𝐞𝐜𝐡𝐧𝐨-𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 (TEA)? 𝐓𝐡𝐢𝐧𝐤 𝐀𝐠𝐚𝐢𝐧! 𝐎𝐫𝐝𝐞𝐫 𝐨𝐟 𝐌𝐚𝐠𝐧𝐢𝐭𝐮𝐝𝐞 𝐄𝐬𝐭𝐢𝐦𝐚𝐭𝐞 (𝐑𝐎𝐌): Or q

The FDA is phasing out Green No. 3, Red No. 40, Yellow No. 5, Yellow No. 6, Blue No. 1, Blue No. 2, and other artificial dyes, by 2026. Food companies urgently need to secure reliable sources of algae, fruit, microbial and plant-derived pigments. 🛠️ 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐑𝐞𝐚𝐝𝐲 𝐭𝐨 𝐒𝐞𝐢𝐳𝐞 𝐭𝐡𝐞 𝐌𝐨𝐦𝐞𝐧𝐭? 𝐁𝐞𝐧𝐜𝐡𝐦𝐚𝐫𝐤𝐢𝐧𝐠: Have you stress-tested your natural-pigment process against synthetic dyes in terms of cost, yield and supply reliability? 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜..

One concise, 𝐟𝐨𝐮𝐧𝐝𝐞𝐫-𝐟𝐫𝐢𝐞𝐧𝐝𝐥𝐲 𝐜𝐡𝐞𝐜𝐤𝐥𝐢𝐬𝐭 to help you decide if you're ready to invest in a Techno-Economic Analysis (TEA). 𝐈𝐭 𝐡𝐞𝐥𝐩𝐬 𝐲𝐨𝐮: ✅ Assess whether your process is mature enough for a meaningful TEA ✅ Identify if key variables are defined enough for modelling ✅ Avoid starting a TEA too early or too late ✅ Clarify if you're gathering data just for internal use or to support funding conversations ✅ Make informed decisions on when and